SEC Form 4 · accession 0001140361-17-019558
NRC HEALTH · NRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Mowry
Director
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 12:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070487
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $24.35 | May 9, 2017 | A | 36,000 | A | May 9, 2018 | May 9, 2027 | Class A Common Stock | 36,000 | 36,000 | D |
| Director Stock Option (Right to Buy) | $44.47 | May 9, 2017 | A | 6,000 | A | May 9, 2018 | May 9, 2027 | Class B Common Stock | 6,000 | 6,000 | D |
| Director Stock Option (Right to Buy) | $14.95 | holding | — | — | — | May 8, 2015 | May 8, 2024 | Class A Common Stock | 72,000 | 72,000 | D |
| Director Stock Option (Right to Buy) | $14.21 | holding | — | — | — | May 7, 2016 | May 7, 2025 | Class A Common Stock | 36,000 | 36,000 | D |
| Director Stock Option (Right to Buy) | $14.19 | holding | — | — | — | May 11, 2017 | May 11, 2026 | Class A Common Stock | 36,000 | 36,000 | D |
| Director Stock Option (Right to Buy) | $43.91 | holding | — | — | — | May 8, 2015 | May 8, 2024 | Class B Common Stock | 12,000 | 12,000 | D |
| Director Stock Option (Right to Buyer) | $34.50 | holding | — | — | — | May 7, 2016 | May 7, 2025 | Class B Common Stock | 6,000 | 6,000 | D |
| Director Stock Option (Right to Buy) | $37.78 | holding | — | — | — | May 11, 2017 | May 11, 2026 | Class B Common Stock | 6,000 | 6,000 | D |